Mid
I
IRTCAI Stock Diagnostic Report
IRhythm outlines $880M-$890M 2026 revenue outlook as it targets 13%-14% adjusted EBITDA margin and plans Vital Connect close by year-end
iRhythm reported a 20.1% increase in revenue for the second quarter and raised its revenue outlook for 2026, highlighting its ongoing growth momentum.
View Source Article ↗AI CATALYST SCORE85 / 100Score computed by Sentinel V12
REFERENCE PRICE$128.12Reference entry price at analysis time
01
FUNDAMENTALS
Financial & Fundamental Analysis
In the second quarter, revenue reached $224.2 million, marking a 20.1% increase compared to the same period last year, achieving over 20% growth for the seventh consecutive quarter, and demonstrating solid fundamentals with an annual revenue forecast for 2026 projected at $880 million to $890 million.
02
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
The company provided annual revenue guidance for 2026, announced a target adjusted EBITDA margin of 13%-14%, and outlined plans to complete the acquisition of Vital Connect within the year, securing ongoing business expansion momentum.